ThePennychemist directly from the quarterly looks like the technology from a GeoMega will be shared with MTM to help them develop their project and compete in any price fluctuations of REE in the future. Absolutely amazing and missed this from the quarterly
“Geomega underwent a strategic change in direction in 2016 away from exploration in order to focus on mineral processing technologies. They have subsequently de-merged their exploration portfolio (apart from the Pomme and Montviel projects) and developed a proprietary and patented metallurgical process (US15/578,498) for the treatment of the REE Page 7 mineralisation. This process technology is currently in optimisation stage. MTM will engage further with Geomega as exploration advances with a view to being given the opportunity to test their technology as a potential processing option for a future development of the Pomme project.”
- Forums
- ASX - By Stock
- MTM
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
MTM
mtm critical metals limited
Add to My Watchlist
3.39%
!
57.0¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-88
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
57.0¢ |
Change
-0.020(3.39%) |
Mkt cap ! $263.2M |
Open | High | Low | Value | Volume |
59.0¢ | 60.0¢ | 56.0¢ | $4.018M | 6.968M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 8394 | 57.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
58.0¢ | 70000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 8394 | 0.570 |
3 | 52769 | 0.565 |
7 | 89102 | 0.560 |
5 | 212582 | 0.555 |
24 | 213279 | 0.550 |
Price($) | Vol. | No. |
---|---|---|
0.580 | 50000 | 1 |
0.585 | 35000 | 1 |
0.590 | 5000 | 1 |
0.595 | 10000 | 1 |
0.600 | 18888 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MTM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online